Orbimed Capital LLC
CIK 0001157524
Director10% Owner
Filings
14
Latest Apr 23, 2026
Issuers covered
6
Showing
14 of 14
Page 1
Track record
19 of 38 open-market trades scored (50% price coverage) - 19 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 19 | 47% | +3.4% | -5.6% | +32.6% | -10.2% |
| 90 days | 17 | 29% | +1.2% | -3.9% | +37.0% | -38.9% |
| 180 days | 17 | 94% | +14.7% | +8.1% | +48.1% | -37.1% |
| 365 days | 17 | 65% | +31.4% | +41.4% | +77.8% | -25.2% |
Issuers
Companies where Orbimed Capital LLC has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| KNTE | Kinnate Biopharma Inc. | 5 | Apr 5, 2024 |
| SPRY | Ars Pharmaceuticals, Inc. | 3 | Aug 28, 2024 |
| ARQT | Arcutis Biotherapeutics, Inc. | 2 | Jun 28, 2022 |
| PRLD | Prelude Therapeutics Inc | 2 | Apr 23, 2026 |
| PMVP | Pmv Pharmaceuticals, Inc. | 1 | Mar 31, 2022 |
| SRRA | Sierra Oncology, Inc. | 1 | Jan 28, 2022 |
All filings
14 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|